SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MSI NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

ROCHE: Click to view the issuer\'s details

Last update : 16/08/2018  >View issuer details

2020.01.24 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche provides an update on Phase III study of Tecentriq in people with muscle-invasive urothelial cancer - HTML (w)

2020.01.23 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche’s Risdiplam meets primary endpoint in pivotal FIREFISH trial in infants with type 1 spinal muscular atrophy - HTML (w)

2020.01.21 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma - HTML (w)

2020.01.13 | 17:55 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche and Illumina partner to broaden patient access to genomic testing - HTML (w)

2019.12.17 | 14:55 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche concludes acquisition of Spark Therapeutics, Inc. to strengthen presence in gene therapy - HTML (w)

2019.12.17 | 07:00 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Roche purchases shares in tender offer for Spark Therapeutics, Inc. - HTML (w)

2019.12.16 | 08:23 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche and Spark Therapeutics, Inc. announce unconditional clearance by UK Competition and Markets Authority - HTML (w)

2019.12.11 | 14:00 | Permanent Information Releases / Sales and Revenues

English version HTML (w) Mail

puce APHINITY six-year results strengthen evidence of clinical benefit with Roche’s Perjeta-based regimen - HTML (w)

2019.12.10 | 07:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Roche receives CE Mark for its Accu-Chek SugarView app - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 265